Loading...
Loading...
India's protein imports from SINGAPORE total $112.2K across 20 shipments from 10 foreign suppliers. LIFE TECHNOLOGIES HOLDINGS PTE LTD leads with $33.1K in import value; the top 5 suppliers together control 98.6% of this origin. Leading Indian buyers include INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for protein — a diversified sourcing base with multiple active suppliers from SINGAPORE.

LIFE TECHNOLOGIES HOLDINGS PTE LTD is the leading Protein supplier from SINGAPORE to India, with import value of $33.1K across 2 shipments. The top 5 suppliers — LIFE TECHNOLOGIES HOLDINGS PTE LTD, GLOBAL LIFE SCIENCES SOLUTIONS SINGAPORE PTE LTD.,, GLOBAL LIFE SCIENCES SOLUTIONS SINGAPORE PTE. LTD., GLOBAL LIFE SCIENCES SOLUTIONS SINGAPORE PTE LTD, SINGLAB TECHNOLOGIES PTE LTD — collectively account for 98.6% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | LIFE TECHNOLOGIES HOLDINGS PTE LTD | $33.1K | 2 | 29.5% |
| 2 | GLOBAL LIFE SCIENCES SOLUTIONS SINGAPORE PTE LTD., | $29.4K | 4 | 26.2% |
| 3 | GLOBAL LIFE SCIENCES SOLUTIONS SINGAPORE PTE. LTD. | $25.3K | 2 | 22.5% |
| 4 | GLOBAL LIFE SCIENCES SOLUTIONS SINGAPORE PTE LTD | $19.3K | 3 | 17.2% |
| 5 | SINGLAB TECHNOLOGIES PTE LTD | $3.6K | 1 | 3.2% |
| 6 | LIFE TECHNOLOGIES HOLDING PTE LTD | $927 | 2 | 0.8% |
| 7 | GENSCRIPT BIOTECH(SINGAPORE) PTE LTD | $285 | 3 | 0.3% |
| 8 | LIFE TECHNOLOGIES HOLDINGS PTE LIMITED | $143 | 1 | 0.1% |
| 9 | LIFE TECHNOLOGIES HOLDING PTE LIMITED | $133 | 1 | 0.1% |
| 10 | IMMUNOLOGY PROGRAMME | $36 | 1 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED | $33.3K | 3 | 29.6% |
| 2 | MERIL DIAGNOSTICS PRIVATE LIMITED | $25.3K | 2 | 22.5% |
| 3 | SPINCOTECH PRIVATE LIMITED | $23.5K | 3 | 20.9% |
| 4 | ADVY CHEMICAL PRIVATE LIMITED | $19.3K | 3 | 17.2% |
| 5 | HYCLONE LIFE SCIENCES SOLUTIONS INDIA PRIVATE LIMI | $5.9K | 1 | 5.3% |
| 6 | A.I.C. SPECIALITIES | $3.6K | 1 | 3.2% |
| 7 | Syngene International Limited Unit IV BLOCK S 12 | $1.1K | 3 | 0.9% |
| 8 | ATHENESE-DX PRIVATE LIMITED | $285 | 3 | 0.3% |
| 9 | BLUE OCEAN ENTERPRISES | $36 | 1 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Protein suppliers from SINGAPORE to India include LIFE TECHNOLOGIES HOLDINGS PTE LTD, GLOBAL LIFE SCIENCES SOLUTIONS SINGAPORE PTE LTD.,, GLOBAL LIFE SCIENCES SOLUTIONS SINGAPORE PTE. LTD.. The leading supplier is LIFE TECHNOLOGIES HOLDINGS PTE LTD with import value of $33.1K USD across 2 shipments. India imported Protein worth $112.2K USD from SINGAPORE in total across 20 shipments.
India imported Protein worth $112.2K USD from SINGAPORE across 20 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Protein sourced from SINGAPORE include INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED, MERIL DIAGNOSTICS PRIVATE LIMITED, SPINCOTECH PRIVATE LIMITED. The largest buyer is INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED with $33.3K in imports across 3 shipments.
The total value of Protein imports from SINGAPORE to India is $112.2K USD, across 20 shipments and 10 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
20 Verified Shipments
10 suppliers, 9 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists